In head and cancer there is a need for a predictive biomarker for patients undergoing radiotherapy(RT) to allow personalisation of treatment.55 patients with HNSCC had DWI imaging performed at baseline, during (week 2, 3, 5 and 6) and post RT (1 and 3 months). Absolute and change in primary tumour ADCmean was correlated to local recurrence.Week 3 was the optimal timepoint for mid-treatment response assessment. Change in week 3 ADCmean of <24.4% predicted local recurrence; corresponding 2 year LRFS of 97% vs 42%.Changes in mid-treatment DWI imaging could be utilised in design of future adaptive clinical trials.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords